Genmab A/S (0MGB)
LSE
2,101.00
-68.00 (-3.14%)
Closed
Aug 24, 2026
Day's Range
2,092.002,127.00
52 wk Range
1,514.502,256.00
Financial Statements - 0MGB - Genmab A/S
Revenue
3.72B▲ 23.9%
Net Income
963.00M▼ 12.0%Net Margin 25.9%
EBITDA
1.45B▲ 24.3%
Free Cash Flow
1.13B▲ 8.6%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 3.72B | 3B | 16.47B | 14.50B | 8.41B | 10.11B |
| Cost of Goods | 238M | 137.42M | 226M | 0 | 0 | - |
| Gross Profit | 3.48B | 2.86B | 16.24B | 14.50B | 8.41B | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 1.25B | 977.03M | 5.32B | 6.26B | 2.95B | 6.31B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -123M | 179.41M | -596M | 393M | 781M | -583M |
| Pre Tax Income | 1.20B | 1.27B | 5.63B | 6.94B | 3.91B | 5.90B |
| Income Tax | 241M | 184.16M | 1.28B | 1.49B | 961M | 1.14B |
| Net Income | 963M | 1.09B | 4.35B | 5.45B | 2.95B | 4.75B |
| EPS Basic | 15.5 | 17.050338 | 66.64 | 83.38 | 46 | 73 |
| EPS Diluted | 15.37 | 16.931748 | 66.02 | 82.59 | 45.54 | 72.21 |
| Basic Shares Outstanding | 62.15M | 406.99M | 65.30M | 65.38M | 65.63M | 65.17M |
| Diluted Shares Outstanding | 62.15M | 406.99M | 65.30M | 65.38M | 65.63M | 65.17M |
| Ebit | 1.26B | 1.29B | 5.70B | 6.98B | 3.93B | 5.91B |
| Ebitda | 1.45B | 1.17B | 6.59B | 6.95B | 3.39B | 6.75B |
| Net Income Continuous Operations | 1.20B | 1.27B | 5.63B | 6.94B | 3.91B | 5.90B |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
